Loading insider details...
Beta
Latest Form 4 (May 18, 2026): Grant/Award of 4,137 LNTH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 18, 2026 | Lantheus Holdings, Inc. (LNTH) | Grant/Award | 4,137 | n/a |
| May 16, 2025 | Lantheus Holdings, Inc. (LNTH) | Grant/Award | 2,537 | n/a |
| Feb 11, 2025 | Lantheus Holdings, Inc. (LNTH) | Grant/Award | 563 | n/a |
| Oct 17, 2023 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 16,667 | n/a |
| May 25, 2023 | CRISPR Therapeutics AG (CRSP) | Exercise/Conversion | 6,938 | n/a |
| Mar 14, 2023 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 44,620 | n/a |
| Oct 12, 2022 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 9,380 | n/a |
| May 24, 2022 | CRISPR Therapeutics AG (CRSP) | Grant/Award | 27,750 | n/a |